Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newborn screening for adrenoleukodystrophy: implications for therapy.

Gerald V Raymond1, Richard O Jones, Ann B Moser

  • 1Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA. Raymond@kennedykrieger.org

Molecular Diagnosis & Therapy
|December 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Driving treatment for females with X-linked adrenoleukodystrophy.

Molecular genetics and metabolism·2026
Same author

Genetic analysis of the X-linked adrenoleukodystrophy gene ABCD1 in Drosophila uncovers a conserved phenotype.

Communications biology·2026
Same author

In vivo base editing rescues liver pathophysiology and peroxisome dysfunction in a mouse model of Zellweger spectrum disorder.

Nature biomedical engineering·2026
Same author

Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Dysregulated hippocampal fatty acid metabolism following intermittent hypoxemia-induced neonatal brain injury is rescued by treatment with acetate.

Nature communications·2025
Same author

Risk of Seizures and Epilepsy in the Leukodystrophies.

Pediatric neurology·2025
Same journal

Multiplex RT-PCR-Based Sequencing Assay to Detect Kidney Cancer-Specific Splice Variants in Tumor Tissues and Plasma Cell-Free RNAs.

Molecular diagnosis & therapy·2026
Same journal

Individualized Longitudinal ctDNA Monitoring in Melanoma Using Multiplexed USE-PCR.

Molecular diagnosis & therapy·2026
Same journal

Advances in Gene and Cellular Therapy in Friedreich Ataxia.

Molecular diagnosis & therapy·2026
Same journal

Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer.

Molecular diagnosis & therapy·2026
Same journal

Tividenofusp Alfa: First Approval.

Molecular diagnosis & therapy·2026
Same journal

Genetics of Cerebrotendinous Xanthomatosis.

Molecular diagnosis & therapy·2026
See all related articles

Early detection of X-Linked adrenoleukodystrophy (X-ALD) is crucial for preventing severe health issues. A new tandem mass spectrometry method enables X-ALD detection through newborn screening, improving patient outcomes.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • X-Linked adrenoleukodystrophy (X-ALD) is a progressive metabolic disorder impacting males.
  • It affects adrenal glands and the nervous system, with a severe childhood form in 35% of cases.
  • Adrenal insufficiency is common, potentially leading to crisis.

Purpose of the Study:

  • To review the rationale for early X-ALD detection.
  • To discuss the impact of early detection on treatment strategies.
  • To address current uncertainties regarding X-ALD management.

Main Methods:

  • Development of a tandem mass spectrometry method.
  • Integration of this method into newborn screening protocols.
  • Review of existing literature on X-ALD phenotypes and management.

Related Experiment Videos

Main Results:

  • Tandem mass spectrometry allows for early detection of X-ALD.
  • Early detection facilitates timely intervention and management.
  • The study highlights the potential to prevent morbidity associated with X-ALD.

Conclusions:

  • Early detection of X-ALD through newborn screening is highly desirable.
  • Newborn screening can identify affected individuals before symptom onset.
  • Further research is needed to address management uncertainties.